One vial of blood could provide an important clue about what’s happening inside the brain. The FDA has cleared ELECSYS ...
The Sam Altman-backed longevity biotech company is upping the dose of its experimental Alzheimer's drug in clinical trials.
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...
The FDA approved Roche Diagnostics and Eli Lilly’s blood test to help doctors assess Alzheimer’s disease in people 55 and ...
Dr. Ian Grant, behavioral neurologist at Northwestern Medicine’s Cognitive Neurology & Alzheimer’s Disease Center, joins Bob ...
The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...
The adult human brain has limited capacity to repair or regenerate neurons lost to Alzheimer's disease, the most common type of dementia. Existing treatments can slow disease progression but do not ...
Two University of Wyoming faculty members will further their research in understanding the microcircuit changes that occur in ...
In this episode titled, 'Alzheimer's Disease Prevalence and Prevention: Building the Case for Early Diagnosis,' Kavita Nair, PhD ...
When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning ...
Nevada Rural Counties RSVP Program, Inc. (RSVP) is pleased to announce that Chief Executive Officer Molly Walt has been ...
A new study has found that women who go through menopause earlier may develop Alzheimer's disease (AD) sooner in later life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results